+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Urethral Stricture Drug"

Urethral Stricture Treatment Market Outlook 2026-2034: Market Share, and Growth Analysis by Treatment Type (Surgical Treatments, Endoscopic / Minimally-Invasive Treatments, Non-Surgical / Dilation-Based Management, Laser Therapy), Product Type, Etiology, Patient Type - Product Thumbnail Image

Urethral Stricture Treatment Market Outlook 2026-2034: Market Share, and Growth Analysis by Treatment Type (Surgical Treatments, Endoscopic / Minimally-Invasive Treatments, Non-Surgical / Dilation-Based Management, Laser Therapy), Product Type, Etiology, Patient Type

  • Report
  • July 2026
  • 160 Pages
  • Global
From
Urethral Stricture Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Urethral Stricture Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • November 2024
  • 96 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

The Urethral Stricture Drug market is a subset of the Urological Disorders Drugs market. It is composed of drugs used to treat urethral strictures, which are abnormal narrowing of the urethra. These drugs are used to reduce inflammation, relax the urethral muscles, and reduce the risk of further narrowing. Commonly used drugs include alpha-blockers, anticholinergics, and 5-alpha reductase inhibitors. In some cases, surgery may be necessary to treat the stricture. The Urethral Stricture Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, Merck, AstraZeneca, GlaxoSmithKline, and Novartis. Other companies include Sanofi, Bayer, and Allergan. Show Less Read more